Pharmafile Logo

FDA Map

FDAMAP is a group of global healthcare experts that conducts highly informative conferences, workshops and other training sessions for pharma, diagnostics and medical device industry professionals. Our panels of speakers include experts in clinical trials, data management, statistics, regulatory affairs, safety reporting, pharmacovigilance, social media marketing of medical products (drugs, biologics and medical devices), project management, GMP, GCP GLP, FDA/EMA audits, and information technology. Learn more about our Training and Consultancy Programs (Regulatory Workshops, FDA Seminars and Conferences, and Regulatory Consultancy) on our website www.fdamap.com

We work with professionals, regulators, and government agencies to build unique platforms for consultation, training, networking, and professional development. We strive hard to make high quality, mutually beneficial relationships with our customers and partners alike.

The FDAMap initiative is the newest venture of a group of leading experts from the industry and government to bring professionals at all levels together to create best practices based on logic, logistics, legal, and least-burdensome compliance. Visit: www.fdamap.com

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

20203 Goshen Rd,, Suite 261 Gaithersburg, Gaithersburg, Maryland, MD 20879, United States
+1-410-501-5777

 Latest Content from PMHub 

Virtual Reality in Medicine and Clinical Research

In the latest episode of Impetus Digital's Fireside Chat, I sit down with Ville Leppälä, Vertical Lead, Research and Medical, at Varjo. We discuss the potential applications of virtual reality, augmented...

Award-winning agency Porterhouse Medical Group joins imc group with Waterland Private Equity’s support

Porterhouse Medical Group, specialists in medical communications and insights research, is joining imc group with the support of Waterland Private Equity. Porterhouse’s award-winning team will further imc’s ambition to become...

Virtual Engagement At Porterhouse: Reflections on the past few months

A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world.

Introducing Porterhouse Intelligence Hub

Our finger on the pulse of the data that will matter the most

Article: What’s next? How behavioural science can support pharma’s future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Read his latest article for PME Magazine.https://bit.ly/31ef6rh

Video: UX/ Experience design research

Director and UX expert Liza Pliss discusses Research Partnership's approach to user experience research and shares an example of a project where using design thinking led to an agile approach...

White paper: The impact of COVID-19 on chronic disease management

Therapy Watch, Research Partnership's syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management. In this white paper, Research Partnership share some of the insights and...

Covid-19 drives change in long-term conditions management

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home

Potential Benefits and Dangers of Big Data Analytics

In this episode of Impetus Digital's Fireside Chat, I sit down with Brenda McPhail from the Canadian Civil Liberties Association. We talk about a myriad of different subjects related to...

VR/AR Applications for Training and Healthcare

In the latest episode of Impetus Digital's Fireside Chat, I sit down with Mike Waldron, who is the CEO and Co-Founder of Propel VR. We discuss how virtual reality (VR)...